MatrixCellect® 100 DBM

Demineralised Bone Matrix for the treatment of skeletal defects.

Contact for pricing Read more

home / tissue products / orthopaedics / view product

MatrixCellect® 100 DBM

MatrixCellect® 100 Demineralised Bone Matrix (DBM) is derived from 100% bone allograft with no extrinsic carriers. It is used for the treatment of surgically created or traumatic skeletal defects. Processed using CellRight Technologies® proprietary demineralisation process, it has been histologically proven to exhibit all five elements of bone formation post-sterilisation.

Brochure

Features

MatrixCellect 100 DBM offers:

Two-year shelf life

Stored at ambient temperature (2-30°C)

Sterility Assurance Level (SAL) of 10-6

Osteoinductive – each lot is verified

Options

Available in ready to use syringes of multiple sizes.

MatrixCellect® 100 DBM Putty: demineralised bone matrix

MatrixCellect® 100 DBM Crunch: demineralised bone matrix containing mineralized cancellous chips

Whether you are conducting groundbreaking research, clinical trials, or require biospecimens for diagnostic purposes, Biostór is your trusted partner for ethical, efficient, and high-quality biospecimen procurement.

MatrixCellect® 100 DBM

MatrixCellect® 100 DBM

Features

Options

Our Clients, Partners & Collaborators